Ionis Pharma (IONS) Misses Q4 EPS Views

Ionis Pharma (NASDAQ: IONS) reported Q4 EPS of ($0.59), $0.11 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $51.6 million versus the consensus estimate of $49.32 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.

You May Also Be Interested In

• Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
• Honeywell Technologies revises 2026 EPS guidance after stock split
• Jefferies Comments on Lululemon (LULU) Following Channel Checks